VAERS reports by lot

Moderna COVID-19 lot 021B21A-1: VAERS reports

63 VAERS reports list lot 021B21A-1 as a Moderna COVID-19 vaccine, received between 2021-05-07 and 2022-11-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
63
Reports
6%
Marked serious
1
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4322%
Cardiac / Cardiovascular3719%
Neurological3619%
Gastrointestinal147%
Musculoskeletal126%
Dermatological (non-injection-site)126%
Injection-site / Local reaction126%
Allergic / Anaphylactic74%
Thrombotic / Hematological63%
Respiratory63%
Reproductive / Menstrual53%
Autoimmune / Immune-mediated21%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 3).

California34
Pennsylvania2
Massachusetts1

Reports by month received

2021-0510
2021-0630
2021-074
2021-087
2021-095
2021-111
2021-122
2022-011
2022-022
2022-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.